
Medtech funding has been one of the fastest growing areas of CVC, and here are some of its brightest startups, from brain surgery microbots to holographic surgery technology.
The venture firm is targeting consumer health startups that can prevent illness before it happens and has secured health product maker Schwabe as its financier.
January 2025 saw 53 corporate-backed startup exits, marking a 47% year-on-year increase and the highest total since early 2023, with deal values soaring to $4.52bn.
Clinics offering wraparound care for people taking weight loss drugs have become high-growth businesses, attractive to investors.
Its reputation of political neutrality — and strength in life sciences — is making Singapore a favoured launchpad for western investors and Chinese startups.
The fund will be managed by the US venture capital firm's healthcare team.
Providence will be an anchor investor in the newly independent venture capital firm, Allumia Ventures.
Makowka will manage relationships with AHA Ventures portfolio companies.
GCV has looked through our data to find the busiest investors in corporate venture capital. Here's how and where they invested in 2024.
AI funding rounds commanded huge prices in 2024, but corporate investors also made large bets in healthcare, energy and robotics.
King worked at Intel's corporate venturing arm before joining the investment arm of the newly listed healthcare company.
There was a 62% jump in exits for corporate-backed startups in November, with IPOs and acquisitions across a range of geographies and sectors but also some notable bankruptcies.
Telemedicine didn't solve the fundamental cost problem in healthcare, but new AI models may be tackling this.
Some 37 corporate-backed startups were either acquired or taken public in October, with the total value of exits at $4.37bn, a significant rise on last year.
UK smartphone camera component developer Cambridge Mechatronics’ latest round featured strategic investors Sony Ventures and Intel Capital.
Brendan Bulik-Sullivan, Crystal Huang, Frédérique Dame and Issi Rozen have been promoted from partner positions at the early-stage Alphabet fund.
Wana Schulze and Ivan Yoon will lead CVC investments at Telefónica’s seed and early-stage Brazilian subsidiaries.